Fundraising Fox
/Companies
Sign in

Astek Diagnostics

YC S21

Baltimore, US · Founded 2020 · Delaware corporation · 5 employees · 11 known investors

Find your way into Astek Diagnostics

Sign up to see every warm intro you have to Astek Diagnostics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Astek Diagnostics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Astek Diagnostics develops a diagnostic platform for rapid and accurate detection of urinary tract infections and related conditions in clinical specimens. The company serves physicians and patients needing point-of-care diagnostic solutions for infectious diseases.

Also known as Astek Diagnostics LLC

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMicrofluidicsUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S21)

Astek Diagnostics was founded in 2020 by Mustafa Al-Adhami and Courtney Cavin.

MAMustafa Al-Adhami
Mustafa Al-AdhamiCo-founder · Chief Executive OfficerMustafa Al-Adhami holds a Ph.D. and has experience in customer discovery and diagnostics. He developed the technology for Eugris during his doctoral studies at Baylor and has raised over $5 million in funding for Astek Diagnostics.
CCCourtney Cavin
Courtney CavinCo-founder · Chief Operating OfficerCofounder of Astek Diagnostics, a company building a point-of-care diagnostic platform for rapid detection of urinary tract infections in clinical specimens, where Cavin leads operational strategy, product development, and engineering execution. Cavin also mentors and advocates for STEM in the Baltimore region.30 Under 30 2026

Investors · 11

TEDCOlisted by TEDCOColumbia

How we know: Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

AJGreported

How we know: Y Combinator's founder network · Not right? Tell us

AYANA Capital LLCreportedTampa · $1M – $3M

How we know: a partner's Signal profile · Not right? Tell us

Builder Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

Harvard Management CompanyreportedAllston

How we know: Y Combinator's founder network · Not right? Tell us

K3 DiversityreportedSugar Land

How we know: Y Combinator's founder network · Not right? Tell us

Klar PartnersreportedLondon · $27.5M – $275M

How we know: a partner's Signal profile · Not right? Tell us

She's Independentreported

How we know: shesindependent.com · Not right? Tell us

Thomas Jamesreported

How we know: Y Combinator's founder network · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$4.2M disclosed across 6 rounds · 2020–2025

▶$750KraisedApr 2025 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$750K
Minimum investment
$5K
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedOct 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer
Offering amount
$2.5M
Amount sold
$1.1M
Minimum investment
$5K
First sale
Oct 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$345KraisedAug 2023 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$345K
Amount sold
$345K
Minimum investment
$5K
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedAug 2023 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.4M
Minimum investment
$5K
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$350KraisedAug 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$350K
Amount sold
$350K
Minimum investment
$5K
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedAug 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$150K
Amount sold
$150K
Minimum investment
$5K
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Indee LabsIndee Labs develops Hydropore™, a non-viral microfluidic technology for delivering molecules, nucleic acids, proteins, and gene-editing complexes into immune cells for engineered cell therapy research and manufacturing. The platform enables rapid production of high-quality T-cell immunotherapies and other cell therapies with preserved cell function.
PreDxion BioPreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.
Correlia BiosystemsCorrelia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL. Aimed at pharmaceutical and proteomics researchers, it offers a faster alternative to traditional ELISA for protein measurement in laboratory workflows.
Persist AIPersist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.
Spire HealthSpire Health provides continuous respiratory monitoring devices used by pulmonologists and patients to track lung disease. The company's sensors enable remote tracking of chronic respiratory conditions across the United States.

Companies working in the same space as Astek Diagnostics.

Legal entities · 1

corporate structure
Astek Diagnostics Inc.

Frequently asked questions

What does Astek Diagnostics do?
Astek Diagnostics develops a diagnostic platform for rapid and accurate detection of urinary tract infections and related conditions in clinical specimens. The company serves physicians and patients needing point-of-care diagnostic solutions for infectious diseases.
Who founded Astek Diagnostics?
Astek Diagnostics was founded by Mustafa Al-Adhami, Courtney Cavin in 2020.
Who are Astek Diagnostics's investors?
Astek Diagnostics's investors include Maryland TEDCO, TEDCO, Y Combinator, AJG, AYANA Capital LLC, Builder Capital, Harvard Management Company, K3 Diversity and 3 more.
How much funding has Astek Diagnostics raised?
Astek Diagnostics has disclosed $4.2M raised across 6 rounds.
Where is Astek Diagnostics headquartered?
Astek Diagnostics is headquartered in Baltimore, US.